Company Filing History:
Years Active: 2014
Title: Maria Lisa Knudsen: Innovator in Hepatitis C Research
Introduction
Maria Lisa Knudsen is a prominent inventor based in Stockholm, Denmark. She has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). Her innovative work has led to advancements in understanding and researching this complex virus.
Latest Patents
Maria Lisa Knudsen holds a patent for an "Efficient cell culture system for hepatitis C virus genotype 2B." This invention involves the development of hepatitis C virus 2b/2a intergenotypic recombinants. The JFH1 structural genes (Core, E1, and E2), p7, and the complete NS2 were replaced by the corresponding genes of the genotype 2b reference strain J8. Sequence analysis of the recovered 2b/2a recombinants from two transfection experiments revealed that 2b/2a was genetically stable. The developed 2b/2a viruses provide a robust in vitro tool for research in HCV genotype 2b, including vaccine studies and functional analysis.
Career Highlights
Maria Lisa Knudsen is affiliated with Hvidovre Hospital, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of hepatitis C and its various genotypes.
Collaborations
She has collaborated with notable colleagues, including Judith Margarete Gottwein and Troels Kasper Høyer Scheel. These collaborations have further enriched her research and contributed to the scientific community's knowledge of hepatitis C.
Conclusion
Maria Lisa Knudsen's innovative contributions to hepatitis C research highlight her role as a leading inventor in the field. Her patent and ongoing work continue to pave the way for advancements in virology and potential therapeutic solutions.